Company Overview
−Removed: We are a multi-state cannabis operator in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values.
+Added: We are a multi-state cannabis operator (“MSO”) in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values.
We develop, own, and manage seed to sale state-licensed, state-of-the-art, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis.
We have created and continue to develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing our proprietary strains and formulations.
−Removed: We also license our proprietary brands, along with other top cannabis products, in domestic markets.
−Removed: Our common stock trades on both the OTCQX and the Canadian Securities Exchange under the ticker symbol MRMD.
+Added: We also license our proprietary brands, in select domestic markets, although licensing revenues are not material to our overall results of operations.
+Added: Cannabis remains illegal under United States federal law.
+Added: Our operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which we operate.
Company History
−Removed: In 2014, we entered the cannabis industry as an advisory and real estate management firm that procured state-issued cannabis licenses on behalf of our clients, developed cannabis facilities that we leased to these newly licensed companies, and provided industry-leading expertise and oversight in all aspects of their cannabis operations.
−Removed: In 2018, we made the strategic decision to transition from an advisory business to a direct owner and operator of cannabis licenses in high-growth states.
+Added: We entered the cannabis industry as an advisory and real estate management firm that procured state-issued cannabis licenses on behalf of our clients, developed cannabis facilities that we leased to these newly licensed companies, and provided industry-leading expertise and oversight in all aspects of their cannabis operations.
+Added: In 2018, we made the strategic decision to transition from an advisory business to a direct owner and operator of cannabis licenses in high-growth states, primarily in Eastern and Midwestern states.
Key to this transition was the acquisition and consolidation of our clients for whom we had played a key role in their success, including securing their cannabis licenses, developing facilities that are models of excellence, funding their operations, and providing operational and corporate guidance.
−Removed: We have successfully acquired and integrated certain client businesses in several states, and believe that our prior experience in managing these businesses has provided us with the skills and expertise required to manage the continuing growth of these operations.
−Removed: Throughout our history, we have created our own brands of craft-quality cannabis flower, concentrates, edibles, and other precision-dosed products, which have been award winners and top sellers in multiple states.
+Added: By early 2025, we had substantially completed the acquisition and integration of these clients' businesses.
+Added: Our operations were expanded by additional M&A activity during this period, and today we are one of the larger MSOs in the U.S.
+Added: based on reported annual revenue.
+Added: Throughout our history, we have created our own brands of craft-quality cannabis flower, concentrates, edibles, and other precision-dosed products, which have been recognized through industry awards and strong sales performance in multiple states.
Applying proprietary cultivation and processing procedures and following the strictest quality standards, our portfolio of brands was developed to fill gaps in the marketplace and meet specific effects desired by today’s cannabis consumer.
−Removed: We invest in ongoing research and development and intend to continue to introduce new and innovative products in the future.
−Removed: Today, we operate state-of-the-art, regulatory compliant cannabis cultivation and processing facilities that grow and manufacture our proprietary, high quality, branded cannabis consumer products.
+Added: We believe owning brands that are among the most successful and accessible in the country is critical to our long-term growth.
+Added: To achieve our goal, we invest in ongoing research and development and intend to continue to introduce new and innovative products.
+Added: We believe the strength of our brand portfolio has been recognized as a key differentiator from other MSOs.
+Added: Wholesale Operations
+Added: We operate state-of-the-art, regulatory-compliant cannabis cultivation and processing facilities that grow and manufacture our proprietary, high quality, branded cannabis consumer products.
We distribute our products via the wholesale market to hundreds of dispensaries operated by other cannabis license holders.
−Removed: We also operate our own dispensaries, which are recognized for their excellent customer service and product selection.
−Removed: Revenue is generated at these dispensaries through the sales of our own products and those marketed by other cannabis license holders.
We utilize dedicated sales teams to sell our products to wholesale buyers representing the dispensaries operated by other cannabis license holders.
−Removed: Customers at our own dispensaries purchase cannabis for, among other reasons, the relief of pain and stress, to promote better sleep, and to address other health and wellness needs.
We deploy a variety of marketing strategies to drive the sales of our products, including customer loyalty programs, digital advertising, in-store displays and public relations.
−Removed: We also generate nominal revenue from licensing, management fees, and real estate income.
+Added: Retail Operations
+Added: We also operate our own dispensaries, which are recognized for their excellent customer service and product selection.
+Added: Customers at our dispensaries purchase cannabis for a variety of adult-use and medical purposes, including relaxation, sleep support, and general wellness, consistent with applicable state regulations.
+Added: Revenue is generated at these dispensaries through the sales of our own products and those marketed by other cannabis license holders.
+Added: We also generate limited revenue from licensing, management fees, and real estate income, none of which are material to our consolidated results of operations.
Our Strategic Growth Plan
−Removed: We continue to focus on executing our strategic growth plan, with priority on activities that include the following:
−Removed: • Completing the acquisition and consolidation of our original advisory clients:
−Removed: ◦ First State Compassion Center ("FSCC") in Delaware is the last of these businesses, which acquisition we completed on February 28, 2025 in accordance with the Omnibus Agreement between MariMed and FSCC, dated July 1, 2023, that defined the terms under which FSCC's cultivation and processing facilities and two dispensaries would be acquired by MariMed (the "Omnibus Agreement").
+Added: We continue to focus on executing our strategic growth plan, which we refer to as Expand the Brand.
+Added: We prioritize activities that include the following:
• Increasing our product brand revenue by:
5 unchanged sentences
• Increasing retail store revenue by:
−Removed: ◦ driving additional and higher average transactions in our existing stores through an outstanding customer experience that prioritizes our product selection and the ease of the shopping experience;
+Added: ◦ driving additional and higher average transactions in our existing stores through an enhanced customer experience that prioritizes our product selection and the ease of the shopping experience;
◦ expanding our dispensary footprint in current markets where regulations allow and into new markets through new license applications and/or acquisitions of existing cannabis businesses.
−Removed: In November 2023 we announced the closing of a $58.7 million secured credit facility with Needham Bank, a Massachusetts co-operative bank (“Needham Bank”), at a lower rate compared to both our previous debt facility with Chicago Atlantic Admin, LLC (“Chicago Atlantic”) and rates achieved in debt transactions by other cannabis companies.
−Removed: This debt refinancing enabled us to repay our term loan with Chicago Atlantic, satisfy the mortgage on our New Bedford and Middleborough, Massachusetts facilities with Bank of New England, and reduce the principal outstanding on the note we issued to the sellers in connection with our acquisition of the operating assets of Ermont, Inc.
−Removed: The credit facility has allowed us to unencumber our operating assets in Illinois, Ohio and Delaware, as well as our branded products, providing more options for future financing at attractive rates should we choose to increase our borrowings.
+Added: Execution of this strategy is subject to available capital, regulatory approvals, market conditions, and competitive dynamics in each state in which we operate.
Our Competitive Strengths
1 unchanged sentence
Portfolio of Proprietary and Innovative Brands
−Removed: We have developed a portfolio of unique and cannabis market leading brands which are currently distributed in cannabis-legal states.
+Added: We have developed a portfolio of unique and market-leading brands which are currently distributed in cannabis-legal states.
Our brands and products are developed with a consumer first approach and are available in the most popular consumption formats, including whole flower, pre-rolled flower, vape cartridges, concentrates, and edibles.
−Removed: We intend to continue expanding our brand portfolio to meet the effects that today’s cannabis consumers seek.
+Added: We intend to continue to expand our brand portfolio to meet the effects that cannabis consumers seek.
Our portfolio includes several award-winning brands that are among the top sellers in markets where they are available.
2 unchanged sentences
• Betty’s Eddies™ , cannabis fruit chews that deliver better sleep, pain relief, stress relief, and more;
−Removed: The Betty's Eddies line also includes a limited collection of cannabis-infused ice creams created in partnership with ice cream brand Emack & Bolio's ®;
• Bubby’s Baked™ , soft and chewy baked goods and a hot chocolate mix;
−Removed: • Vibations™ , a cannabis-infused hydrating drink mix for discrete, on-the-go consumption;
+Added: • Vibations™ , an infused hydrating drink mix for discrete, on-the-go consumption;
• InHouse™ , a value-priced brand of flower, vapes, and edibles.
Retail Footprint and Operations
−Removed: Our expanding retail footprint and operations drive a significant portion of our revenue and align strategically with our drive to grow a portfolio of proprietary and innovative brands.
−Removed: All retail stores are positioned in states that offer a strong consumer base and favorable regulatory environments that promote market stability.
+Added: Our retail footprint and operations drive a significant portion of our revenue and align strategically with our goal to grow a portfolio of proprietary and innovative brands.
+Added: Our retail stores, all branded Thrive TM following the completion of a national integration initiative in 2025, are in states that offer a strong consumer base and favorable regulatory environments that promote market stability.
We believe today’s cannabis consumer seeks a shopping experience that is comfortable, educational, and easy.
4 unchanged sentences
We intend to do the same in other markets once permitted by state regulations.
−Removed: Finally, our retail footprint and operations enable our ability to drive wholesale distribution through reciprocal relationships (balance of trade relationships) that are common in the cannabis industry.
+Added: Our retail footprint and operations enable our ability to drive wholesale distribution through reciprocal relationships (balance of trade relationships) that are common in the cannabis industry.
This relationship has accelerated MariMed brands, such as Betty’s Eddies , to market leadership positions in most states in which we operate.
Additionally, we gain significant customer insights from our retail operations which allow us to rapidly innovate to meet emerging consumer trends.
−Removed: Combined, our retail footprint and our robust wholesale brand portfolio work together to promote overall growth in revenue, gross profit and market share.
+Added: Combined, our retail footprint and our robust wholesale brand portfolio work together to promote our overall growth in revenue, gross profit and market share.
Experienced Management
Our management team is one of the most experienced and longest tenured in the cannabis industry.
−Removed: Several of our executive team members, including our President and Chief Executive Officer, our Chief Operating Officer, and our Chief Revenue Officer, have each worked in the industry for a decade or more.
+Added: Several of our executive team members, including our Chief Executive Officer, our Chief Operating Officer, and our Chief Commercial Officer, have each worked in the industry for a decade or more.
Our leadership team has achieved considerable success creating and growing businesses in the industry by successfully applying for cannabis licenses, overseeing the development of cannabis operations and facilities, raising capital to purchase and develop facilities, and conducting operations in adherence with regulations established by individual state governments, including all environmental and social governance requirements.
−Removed: The strength of our executive team is further enhanced by other members who have significant senior management experience and expertise working in beer and alcohol, retail, consumer products, and marketing industries.
+Added: The strength of our executive team is further enhanced by other members who have significant senior management experience and expertise working in financial services, beer and alcohol, retail, consumer products, and marketing.
Current and Pending Operations
1 unchanged sentence
We currently hold a total of 33 cannabis licenses in six states.
−Removed: We believe our investment and expansion initiatives will enable us to capture additional market share and provide us with a stronger presence in the states where we conduct business.
−Removed: We believe that operating as a fully vertical, seed to sale cannabis company provides us the greatest opportunity to maximize revenue and profits in each state where we operate.
−Removed: To date, we are fully vertical through businesses we either own or manage in Illinois, Maryland, Massachusetts, and Delaware.
+Added: We believe that operating as a vertically integrated cannabis company, which we define as owning cultivation, manufacturing, and retail licenses within a single state, provides us the greatest opportunity to maximize revenue and profits.
+Added: To date, we are fully vertical in Illinois, Maryland, Massachusetts, and Delaware.
Our current and pending operations are as follows:
3 unchanged sentences
Massachusetts Cannabis Control Commission).
−Removed: We operate three Panacea Wellness- branded dispensaries in the Boston area:
−Removed: • a dispensary in Middleborough that is licensed for both medical and adult-use cannabis sales ;
−Removed: • an adult-use dispensary in Beverly;
−Removed: • a dispensary in Quincy that had initially been licensed for medical sales and which commenced adult-use cannabis sales in 2024.
+Added: We operate three Thrive- branded dispensaries in the Boston area:
+Added: dispensaries in Middleborough and Quincy that are licensed for both medical and adult-use cannabis sales, and an adult-use dispensary in Beverly.
Our three retail stores are easily accessible to all cannabis consumers in eastern Massachusetts.
1 unchanged sentence
We also operate a cultivation and production facility in New Bedford, as well as a cultivation facility in Quincy.
−Removed: Delaware’s medical cannabis program has approximately 17,000 registered patients, according to the Delaware Department of Health and Social Services 2023 annual report.
−Removed: It legalized adult-use cannabis sales in 2023, with such sales expected to commence in 2025.
−Removed: We provide comprehensive management and real estate services to FSCC, our longstanding client in Delaware.
−Removed: We were instrumental in helping FSCC obtain Delaware’s first-ever seed to sale medical cannabis license in 2014.
−Removed: Today, FSCC operates under two of only eleven cannabis licenses in the state.
−Removed: We developed and currently lease to FSCC a number of facilities, including:
−Removed: • a cultivation facility, production kitchen, and dispensary in Wilmington;
−Removed: • a cultivation facility in Milford;
−Removed: • a dispensary in Lewes.
−Removed: FSCC licenses and distributes all of our top selling edibles brands in the state.
−Removed: We anticipate that we will acquire the assets of FSCC when adult-use sales commence in 2025.
−Removed: State law, which had prevented such a transaction, has been amended as part of the expansion of Delaware’s legal cannabis program.
−Removed: Illinois permits both adult-use and medical cannabis programs.
−Removed: According to the Illinois Department of Financial and Professional Regulation, the state reported over $2 billion in total legal cannabis sales in the rolling twelve months ended June 30, 2024.
−Removed: With a population of nearly 13 million, Illinois is one of the largest and fastest-growing cannabis markets in the United States.
+Added: Delaware operates both adult-use and medical cannabis programs, with adult-use sales having commenced in August 2025.
+Added: According to the state’s Office of the Marijuana Commissioner, Delaware’s cannabis market is estimated to generate $150 million to $215 million in sales annually.
+Added: Following the March 2025 acquisition of our longstanding client in Delaware, First State Compassion Center ("FSC"), we operate Thrive -branded dispensaries in Wilmington and Lewes, a cultivation facility in Milford, and a production kitchen in Wilmington
+Added: Illinois operates both adult-use and medical cannabis programs.
+Added: According to the Illinois Department of Financial and Professional Regulation, the state reported $1.5 billion in total legal cannabis sales in 2025.
We operate five Thrive -branded dispensaries in the state, including an adult-use dispensary in Metropolis, near the Kentucky border, an adult-use dispensary in Casey, near the Indiana border, and an adult-use dispensary in Mt.
1 unchanged sentence
These five locations provide easy access for most residents in southern Illinois and several states that don’t have legal cannabis programs, including Kentucky, Indiana, and Tennessee.
−Removed: In December 2023, we completed construction of and commenced operations of our processing facility in Mt.
−Removed: We began selling certain of our award-winning branded edibles products and InHouse vape products in our own dispensaries and in certain other dispensaries in the state during the final weeks of 2023.
−Removed: We significantly increased distribution of our core products throughout the state in 2024.
−Removed: On September 12, 2024, we received final regulatory approval for cultivation in the Mt.
−Removed: Vernon facility, establishing our Illinois operations as fully vertical.
−Removed: We immediately began our cultivation activities in the facility and expect to distribute Nature’s Heritage flower and vapes throughout the state in the second quarter of 2025.
+Added: We also operate a cultivation and manufacturing facility in Mt.
Maryland operates both adult-use and medical cannabis programs.
−Removed: The state’s adult-use program began on July 1, 2023, making 2024 the first full year of the program.
−Removed: According to the Maryland Cannabis Administration, the state reported $1.1 billion in medical and adult-use cannabis sales during the first 12 months of the adult-use program, positioning it among the top legal cannabis markets in the United States.
−Removed: Our operations are fully vertical in Maryland, including a cultivation and processing facility in Hagerstown which produces and distributes all of our premium branded cannabis flower, concentrates, vapes and edibles.
−Removed: In 2024 we completed the expansion of the facility to increase our cultivation capacity to meet the increased demand for our products.
−Removed: We also operate two Thrive -branded medical and adult-use dispensaries in Maryland.
−Removed: One is located in Annapolis and the other is located in the Upper Marlboro part of Prince George’s County.
−Removed: The Upper Marlboro dispensary became part of our network as the result of the April 9, 2024 acquisition of the medical cannabis retail license and certain assets of Our Community Wellness & Compassionate Care Center, Inc.
−Removed: ("MedLeaf") in exchange for $5.25 million, adjusted for certain items.
−Removed: The purchase consideration was comprised of $2.0 million of cash, a $2.0 million note issued to the sellers of MedLeaf (the "MedLeaf Sellers") at the closing, and shares of our common stock with a fair value of $1.25 million, based on a formulaic calculation, that were issued at the closing.
−Removed: Missouri permits both successful medical and adult-use cannabis programs.
−Removed: According to the Missouri Division of Cannabis Regulation, over $1.4 billion worth of legal cannabis was sold in Missouri in 2024.
−Removed: We announced a management contract in September 2022 that would enable us to sell certain of our award-winning branded edibles products in the state.
−Removed: We experienced significant regulatory delays before receiving approval to begin sales, which commenced in the final weeks of the 2024 calendar year.
+Added: According to the Maryland Cannabis Administration, the state projected $1.2 billion in medical and adult-use cannabis sales in 2025.
+Added: We operate two Thrive -branded medical and adult-use dispensaries in Maryland:
+Added: one in Annapolis and the other in the Upper Marlboro part of Prince George’s County.
+Added: We also operate a cultivation and processing facility in Hagerstown.
Ohio’s successful medical cannabis program expanded to include adult-use sales in June 2024.
−Removed: BDSA, a leading provider of market intelligence for the cannabis industry, estimates that total cannabis sales in Ohio will reach $802 million in 2025.
−Removed: Our Thrive -branded medical cannabis dispensary in Tiffin, which we opened in 2023, received regulatory approval to commence adult-use sales in September 2024.
−Removed: Recent Development
−Removed: On February 28, 2025, we completed the acquisition of FSCC in accordance with the terms of the Omnibus Agreement.
−Removed: We believe this recent development is critical to the implementation of our strategic growth plan.
+Added: Total cannabis sales in Ohio exceeded $1 billion in 2025, according to multiple news sources.
+Added: We operate a Thrive -branded dispensary in Tiffin and own a second license to operate a dispensary in Columbus.
+Added: We manage a client's cultivation and manufacturing operations in Pennsylvania.
+Added: We also entered into a license agreement with a client in 2025 that will enable the distribution of our products in that state following regulatory approvals.
+Added: We anticipate sales to commence in early 2027.
+Added: We are constructing a processing kitchen with a licensing partner in New York that will enable the distribution of our brands in that state following completion of construction and state regulatory approvals.
+Added: We anticipate that product sales will commence in early 2027.
+Added: Recent Developments
+Added: Since December 31, 2025, we have continued to execute our operating and strategic priorities within the framework of evolving federal and state regulatory environments affecting the cannabis industry as described below.
+Added: Regulatory Developments
+Added: Cannabis remains illegal under United States federal law.
+Added: Our cannabis operations continue to be conducted in compliance with applicable state and local laws.
+Added: During 2025 and early 2026, there has been increased public discussion and federal legislative activity regarding potential changes to cannabis and hemp related regulations.
+Added: These proposals include, among other matters, potential restrictions on certain hemp derived cannabinoid products.
+Added: While the timing, scope, and outcome
+Added: of any such proposals remain uncertain, we continue to monitor regulatory developments closely and evaluate their potential impact on our operations and strategy.
+Added: Hemp-Derived Product Initiatives and Regulatory Developments
+Added: During 2025, we expanded certain of our branded product offerings into the hemp-derived cannabinoid market, including products formulated to comply with the federal definition of hemp under the Agriculture Improvement Act of 2018 (the “2018 Farm Bill”).
+Added: These products are intended to leverage our existing brand development, formulation, and distribution capabilities outside of state-licensed cannabis programs.
+Added: The regulatory framework governing hemp-derived cannabinoid products, including products containing delta-8 THC, delta-9 THC derived from hemp, and other cannabinoids, continues to evolve at both the federal and state levels.
+Added: During 2025 and early 2026, various federal and state authorities proposed or implemented changes that may restrict or prohibit certain hemp-derived products, impose additional testing, labeling, or licensing requirements, or otherwise alter the permissible scope of these product offerings.
+Added: As a result, the availability, distribution, and commercial viability of hemp-derived cannabinoid products may vary significantly by jurisdiction and may be subject to change with limited notice.
+Added: We continue to monitor regulatory developments closely and may modify, limit, or discontinue hemp-derived product offerings in certain markets in response to regulatory changes, enforcement activity, or compliance considerations.
+Added: To date, hemp-derived product initiatives represent a limited component of our overall business, and our core operations remain focused on state-regulated medical and adult-use cannabis markets.
+Added: Delaware Adult-Use Market Launch
+Added: In Delaware, adult-use cannabis sales commenced in August 2025.
+Added: Following our March 2025 acquisition of First State Compassion Center, we began operating in a dual medical and adult-use market.
+Added: We have focused on scaling operations in a disciplined manner, including supply chain readiness, staffing, and compliance, as the market expands into adult-use sales.
+Added: Brand and Product Initiatives
+Added: We continue to invest in the development and expansion of our proprietary brand portfolio, including the introduction of new product formats, formulations, and effects designed to align with evolving consumer preferences.
+Added: These initiatives are supported by ongoing investments in cultivation, processing, and quality assurance capabilities to enhance product consistency and reliability.
+Added: Product launches and brand expansion efforts remain subject to state-by-state regulatory approval processes.
+Added: Wholesale and Retail Optimization
+Added: During 2025, we continued to refine our wholesale and retail strategies with a focus on improving operational efficiency, enhancing customer experience, and increasing brand penetration in our core markets.
+Added: This included targeted pricing actions, SKU rationalization, and continued investment in retail staff training and customer engagement programs.
+Added: We also continued to leverage insights from our retail operations to inform wholesale product development and distribution strategies.
+Added: Liquidity and Capital Allocation
+Added: We remain focused on disciplined capital allocation, liquidity management, and balance sheet optimization.
+Added: Our strategic initiatives continue to be evaluated in the context of available capital, regulatory requirements, and market conditions.
In the markets where we currently operate, we face competition from licensed cannabis companies of varying sizes and geographic reach.
2 unchanged sentences
Some of our competitors that create and sell their own products have offerings that are on par with those we offer.
−Removed: We believe that by utilizing our own best practices and operational expertise, we are able to produce premium cannabis products at one of the lowest cost structures in the industry, which enables us to remain competitive in our markets.
−Removed: However, our sales could decline significantly if our competitors develop and market products that are more effective, more convenient, or less expensive than our products.
−Removed: As cannabis products become more mainstream and gain greater acceptance, it is likely that larger and more established companies with greater available resources, including name recognition and national distribution networks, will enter the market.
−Removed: However, we believe that there are many barriers to entry, and to duplicate our licenses, knowledge, and facilities would be costly and time-consuming.
−Removed: We have upgraded our marketing efforts to expand branding and distribution, as well as implemented home delivery, where permissible, and other business strategies developed by more conventional industries.
+Added: believe that by utilizing our own best practices and operational expertise, we are able to produce premium cannabis products at one of the lowest cost structures in the industry, which enables us to remain competitive in our markets.
+Added: However, our sales could decline significantly if our competitors develop and market products that are more effective, easier to purchase and/or use, or less expensive than our products.
+Added: As cannabis products become more mainstream and gain greater acceptance, it is likely that larger and more established companies with greater resources will enter the market.
+Added: However, we believe that there are meaningful barriers to entry, including licensing requirements, capital investment, and regulatory compliance requirements.
+Added: We have upgraded our marketing efforts to expand branding and distribution, as well as implemented home delivery, where permissible, and other business strategies utilized by more conventional industries.
As a result, we have successfully increased the number of retail transactions at our stores and increased market share of our core products sold through wholesale.
1 unchanged sentence
Intellectual Property
−Removed: We own registered trademarks for Betty’s Eddies, Nature’s Heritage , and Thrive , and are pursuing registration of the Bubby’s Baked, InHouse, and Vibations trademarks with the United States Patent and Trademark Office.
+Added: We own registered trademarks for Betty’s Eddies, Bubby’s Baked, InHouse, Nature’s Heritage , Vibations, and Thrive with the United States Patent and Trademark Office.
Our proprietary processing and manufacturing techniques and technologies, while not patented, are kept strictly confidential.
1 unchanged sentence
Our Employees
−Removed: At December 31, 2024, we had a total of 832 employees, of which 715 were full-time, plus an additional 117 employees in the aggregate, primarily full-time, who are employed by our managed cannabis-licensed client and the delivery company in which we hold a minority interest.
+Added: At December 31, 2025, we had a total of 923 employees, of which 808 were full-time.
Website Access to Company Reports
−Removed: Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Definitive Proxy Statements, Current Reports on Form 8-K and all amendments to those reports are available free of charge on the Company’s website at www.marimedinc.com as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC, or as filed with the Canadian securities regulatory authorities on the SEDAR website.
+Added: Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Definitive Proxy Statements, Current Reports on Form 8-K and all amendments to those reports are available free of charge on the Company’s website at www.marimedinc.com as soon as reasonably practicable after such material is electronically filed with, or furnished to, the United States Securities and Exchange Commission (the "SEC"), or as filed with the Canadian securities regulatory authorities on the SEDAR website.
In addition, copies of our annual report will be made available, free of charge, upon written request.
−Removed: Our common stock trades on both the OTCQX and the Canadian Securities Exchange under the ticker symbol MRMD.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.